之江生物（688317）披露拟开展外汇衍生品交易业务，11月06日股价下跌1.34%

Core Viewpoint - Zhijiang Biology (688317) plans to engage in foreign exchange derivative trading to mitigate currency fluctuation risks, with a trading limit of up to $20 million [1] Group 1: Stock Performance - As of November 6, 2025, Zhijiang Biology closed at 22.04 yuan, down 1.34% from the previous trading day, with a total market capitalization of 4.235 billion yuan [1] - The stock opened at 22.34 yuan, reached a high of 22.34 yuan, and a low of 22.02 yuan, with a trading volume of 32.4168 million yuan and a turnover rate of 0.76% [1] Group 2: Business Strategy - The company intends to conduct foreign exchange derivative transactions, including forward contracts, swaps, options, and structured forwards, with qualified domestic large banks as trading counterparts [1] - The trading period is set for 12 months from the date of shareholder meeting approval, and the company will use its own funds without engaging in speculative trading [1] - A management system has been established to outline risk control measures, including limiting trading institutions, enhancing market monitoring, and implementing internal reporting mechanisms [1]